Methods for Activity Analysis of the Proteins that Regulate Histone Methylation

Amy M Quinn1, Anton Simeonov

  • 1NIH Chemical Genomics Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892-3370, USA.

Insights

Identifying novel inhibitors for histone-modifying enzymes is crucial for epigenetic therapy. This review highlights the need for and development of high-throughput screening assays to discover potent and specific small molecules targeting these enzymes in diseases like cancer.

Area of Science:

  • Biochemistry
  • Epigenetics
  • Molecular Biology

Background:

  • Histone methylation enzymes and their recognition domains are implicated in human diseases, including cancer, by altering chromatin structure and transcriptional regulation.
  • These proteins are promising therapeutic targets for epigenetic disruption-related diseases, but effective inhibitors are scarce.
  • Current inhibitors often lack potency and specificity, necessitating the discovery of novel chemical scaffolds.

Purpose of the Study:

  • To review existing biochemical and cellular assays for evaluating histone methylation regulators.
  • To emphasize the importance of developing high-throughput screening (HTS) assays for discovering novel therapeutic agents.
  • To facilitate the identification of small molecules for epigenetic therapy.

Main Methods:

  • Review of biochemical and cellular assay methodologies for histone methylation enzymes.
  • Discussion of assay requirements for high-throughput screening (HTS).
  • Analysis of challenges and progress in assay development for histone-modifying enzymes.

Main Results:

  • A range of biochemical and cellular assays are available for studying histone methylation regulators.
  • The development of sensitive, robust, and HTS-compatible assays is critical for drug discovery.
  • Successful assay development will accelerate the identification of novel chemotypes.

Conclusions:

  • Novel chemotypes are urgently needed for targeting histone-modifying enzymes due to limitations of current inhibitors.
  • Advancements in high-throughput screening assays are essential for discovering potent and specific small molecules.
  • Improved assays will enable the development of targeted epigenetic therapies for various human diseases.

Related Concept Videos

Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer is an enzyme that can...